MI
ONC

Motiv8 Investments’s BeOne Medicines Ltd ONC Stock Holding History

Motiv8 Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2 Buy
+7
New +$2.29K ﹤0.01% 793

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Motiv8 Investments's ONC Position: Q4 2025 in Review

Motiv8 Investments opened a new position in BeOne Medicines Ltd (ONC) in Q4 2025: 7 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #793 among its holdings.

286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Motiv8 Investments held 7 shares of BeOne Medicines Ltd worth $2 as of Q4 2025.
  • BeOne Medicines Ltd was a new Motiv8 Investments position in Q4 2025.
  • BeOne Medicines Ltd made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #793 holding.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.